Abstract
Objective: To determine whether surge conditions were associated with increased mortality. Design: Multicenter cohort study. Setting: U.S. ICUs participating in STOP-COVID. Patients: Consecutive adults with COVID-19 admitted to participating ICUs between March 4 and July 1, 2020. Interventions: None Measurements and Main Results: The main outcome was 28-day in-hospital mortality. To assess the association between admission to an ICU during a surge period and mortality, we used two different strategies: (1) an inverse probability weighted difference-in-differences model limited to appropriately matched surge and non-surge patients and (2) a meta-regression of 50 multivariable difference-in-differences models (each based on sets of randomly matched surge- and non-surge hospitals). In the first analysis, we considered a single surge period for the cohort (March 23 – May 6). In the second, each surge hospital had its own surge period (which was compared to the same time periods in matched non-surge hospitals). Our cohort consisted of 4342 ICU patients (average age 60.8 [sd 14.8], 63.5% men) in 53 U.S. hospitals. Of these, 13 hospitals encountered surge conditions. In analysis 1, the increase in mortality seen during surge was not statistically significant (odds ratio [95% CI]: 1.30 [0.47-3.58], p =.6). In analysis 2, surge was associated with an increased odds of death (odds ratio 1.39 [95% CI, 1.34-1.43], p <.001). Conclusions: Admission to an ICU with COVID-19 in a hospital that is experiencing surge conditions may be associated with an increased odds of death. Given the high incidence of COVID-19, such increases would translate into substantial excess mortality.
Original language | English (US) |
---|---|
Pages (from-to) | 500-509 |
Number of pages | 10 |
Journal | Journal of Intensive Care Medicine |
Volume | 37 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2022 |
Keywords
- COVID-19
- intensive care unit
- mortality
- occupancy
- surge
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19. / for the STOP-COVID Investigators.
In: Journal of Intensive Care Medicine, Vol. 37, No. 4, 04.2022, p. 500-509.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19
AU - for the STOP-COVID Investigators
AU - Keene, Adam B.
AU - Admon, Andrew J.
AU - Brenner, Samantha K.
AU - Gupta, Shruti
AU - Lazarous, Deepa
AU - Leaf, David E.
AU - Gershengorn, Hayley B.
N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Heart, Lung, and Blood Institute (grant number K08HL155407-01, n/a). Funding Information: AJA is an employee of the VA Ann Arbor Healthcare System. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. Participants in Study Group The STOP-COVID Investigators include (* Site Principal Investigator): Baylor College of Medicine: Carl P. Walther*, Samaya J. Anumudu; Baylor University Medical Center: Justin Arunthamakun*, Kathleen F. Kopecky, Gregory P. Milligan, Peter A. McCullough, Thuy-Duyen Nguyen; Beth Israel Deaconess Medical Center: Shahzad Shaefi,* Brian P. O?Gara, Megan L. Krajewski, Sean M. Baskin, Sidharth Shankar, Juan D. Valencia, Ameeka Pannu, Margaret M. Hayes, E. Wilson Grandin; Boston Medical Center: Sushrut S. Waikar*, Zoe A. Kibbelaar; Cook County Health: Ambarish M. Athavale*, Peter Hart, Shristi Upadhyay, Ishaan Vohra, Ajiboye Oyintayo; Cooper University Health Care: Adam Green*, Jean-Sebastien Rachoin, Christa A. Schorr, Lisa Shea; Duke University Medical Center: Daniel L. Edmonston*, Christopher L. Mosher; Hackensack Meridian Health Mountainside Medical Center: Alexandre M. Shehata*, Zaza Cohen, Valerie Allusson, Gabriela Bambrick-Santoyo, Noor ul aain Bhatti, Bijal Mehta, Aquino Williams; Hackensack Meridian Health Hackensack University Medical Center: Samantha K. Brenner*, Patricia Walters, Ronaldo C. Go, Keith M. Rose; Harvard T.H. Chan School of Public Health: Miguel A. Hern?n; Harvard University: Rebecca Lisk; Icahn School of Medicine at Mount Sinai: Lili Chan*, Kusum S. Mathews*, Steven G. Coca, Deena R. Altman, Aparna Saha, Howard Soh, Huei Hsun Wen, Sonali Bose, Emily A. Leven, Jing G. Wang, Gohar Mosoyan, Girish N. Nadkarni, Pattharawin Pattharanitima, Emily J. Gallagher; Indiana University School of Medicine/Indiana University Health: Allon N. Friedman*, John Guirguis, Rajat Kapoor, Christopher Meshberger, Katherine J. Kelly; Johns Hopkins Hospital: Chirag R. Parikh*, Brian T. Garibaldi, Celia P. Corona-Villalobos, Yumeng Wen, Steven Menez, Rubab F. Malik, Carmen Elena Cervantes, Samir C. Gautam; Kings County Hospital Center: Mary C. Mallappallil*, Jie Ouyang, Sabu John, Ernie Yap, Yohannes Melaku, Ibrahim Mohamed, Siddhartha Bajracharya, Isha Puri, Mariah Thaxton, Jyotsna Bhattacharya, John Wagner, Leon Boudourakis; Loma Linda University: H. Bryant Nguyen*, Afshin Ahoubim; Mayo Clinic, Arizona: Leslie F. Thomas*, Dheeraj Reddy Sirganagari; Mayo Clinic, Florida: Pramod K. Guru*; Mayo Clinic, Rochester: Kianoush Kashani*, Shahrzad Tehranian; Medical College of Wisconsin: Yan Zhou,* Paul A. Bergl, Jesus Rodriguez, Jatan A. Shah, Mrigank S. Gupta; MedStar Georgetown University Hospital: Princy N. Kumar*, Deepa G. Lazarous, Seble G. Kassaye; Montefiore Medical Center/Albert Einstein College of Medicine: Michal L. Melamed*, Tanya S. Johns. Ryan Mocerino, Kalyan Prudhvi, Denzel Zhu, Rebecca V. Levy, Yorg Azzi, Molly Fisher, Milagros Yunes, Kaltrina Sedaliu, Ladan Golestaneh, Maureen Brogan, Neelja Kumar, Michael Chang, Jyotsana Thakkar; New York-Presbyterian Queens Hospital: Ritesh Raichoudhury*, Akshay Athreya, Mohamed Farag; New York-Presbyterian/Weill Cornell Medical Center: Edward J. Schenck*, Soo Jung Cho, Maria Plataki, Sergio L. Alvarez-Mulett, Luis G. Gomez-Escobar, Di Pan, Stefi Lee, Jamuna Krishnan, William Whalen; New York University Langone Hospital: David Charytan*, Ashley Macina, Sobaata Chaudhry, Benjamin Wu, Frank Modersitzki; Northwestern Memorial Hospital: Northwestern University Feinberg School of Medicine - Anand Srivastava*, Alexander S. Leidner, Carlos Martinez, Jacqueline M. Kruser, Richard G. Wunderink, Alexander J. Hodakowski; Ochsner Medical Center: Juan Carlos Q. Velez*, Eboni G. Price-Haywood, Luis A. Matute-Trochez, Anna E. Hasty, Muner MB. Mohamed; Oregon Health and Science University Hospital: Rupali S. Avasare*, David Zonies*; Partners Healthcare: Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, Massachusetts General Hospital, and Newton Wellesley Hospital - David E. Leaf*, Shruti Gupta*, Meghan E. Sise, Erik T. Newman, Samah Abu Omar, Kapil K. Pokharel, Shreyak Sharma, Harkarandeep Singh, Simon Correa, Tanveer Shaukat, Omer Kamal, Wei Wang, Heather Yang, Jeffery O. Boateng, Meghan Lee, Ian A. Strohbehn, Jiahua Li, Ariel L. Mueller; ProMedica Health System: Roberta E. Redfern,* Nicholas S. Cairl, Gabriel Naimy, Abeer Abu-Saif, Danyell Hall, Laura Bickley; Renown Health: Chris Rowan*, Farah Madhani-Lovely*; Rush University Medical Center: Vasil Peev*, Jochen Reiser, John J. Byun, Andrew Vissing, Esha M. Kapania, Zoe Post, Nilam P. Patel, Joy-Marie Hermes; Rutgers/New Jersey Medical School: Anne K. Sutherland*, Amee Patrawalla, Diana G. Finkel, Barbara A. Danek, Sowminya Arikapudi, Jeffrey M. Paer, Peter Cangialosi, Mark Liotta; Rutgers/Robert Wood Johnson Medical School: Jared Radbel*, Sonika Puri, Jag Sunderram, Matthew T. Scharf, Ayesha Ahmed, Ilya Berim, Jayanth S. Vatson; Stanford Healthcare: Stanford University School of Medicine ? Shuchi Anand*, Joseph E. Levitt, Pablo Garcia; Temple University Hospital: Suzanne M. Boyle*, Rui Song, Ali Arif; Thomas Jefferson Health: Jingjing Zhang*, Sang Hoon Woo, Xiaoying Deng, Goni Katz-Greenberg, Katharine Senter; Tulane Medical Center: Moh?d A. Sharshir*, Vadym V. Rusnak; United Health Services Hospitals: Muhammad Imran Ali, Terri Peters, Kathy Hughes; University of Colorado Anschutz Medical Campus: Anip Bansal*, Amber S. Podoll, Michel Chonchol, Sunita Sharma, Ellen L. Burnham; University Hospitals Cleveland Medical Center: Arash Rashidi*, Rana Hejal; University of Alabama-Birmingham Hospital: Eric Judd*, Laura Latta, Ashita Tolwani; University of California-Davis Medical Center: Timothy E. Albertson*, Jason Y. Adams; University of California-Los Angeles Medical Center: Ronald Reagan-UCLA Medical Center - Steven Y. Chang*, Rebecca M. Beutler; Santa Monica-UCLA Medical Center ? Carl E. Schulze; University of California-San Diego Medical Center: Etienne Macedo*, Harin Rhee; University of California-San Francisco Medical Center: Kathleen D. Liu*, Vasantha K. Jotwani; University of Chicago Medical Center: Jay L. Koyner*, Alissa Kunczt; University of Florida Health-Gainesville: Chintan V. Shah*; University of Florida-Health-Jacksonville: Vishal Jaikaransingh*; University of Illinois Hospital and Health Sciences System: Stephanie M. Toth-Manikowski*, Min J. Joo*, James P. Lash; University of Kentucky Medical Center: Javier A. Neyra*, Nourhan Chaaban, Madona Elias, Yahya Ahmad; University Medical Center of Southern Nevada: Rajany Dy*, Alfredo Iardino, Elizabeth H. Au, Jill H. Sharma; University of Miami Health System: Marie Anne Sosa*, Sabrina Taldone, Gabriel Contreras, David De La Zerda, Alessia Fornoni, Hayley B. Gershengorn; University of Michigan: Salim S. Hayek*, Pennelope Blakely, Hanna Berlin, Tariq U. Azam, Husam Shadid, Michael Pan, Patrick O? Hayer, Chelsea Meloche, Rafey Feroze, Kishan J. Padalia, Abbas Bitar, Jeff Leya, John P. Donnelly, Andrew J. Admon; University of North Carolina School of Medicine: Jennifer E. Flythe*, Matthew J. Tugman, Emily H. Chang; University of Oklahoma Health Sciences Center: Brent R. Brown*; University of Pennsylvania Health System: Amanda K. Leonberg-Yoo*, Ryan C. Spiardi, Todd A. Miano, Meaghan S. Roche, Charles R. Vasquez; University of Pittsburgh Medical Center: Amar D. Bansal*, Natalie C. Ernecoff, Sanjana Kapoor, Siddharth Verma, Huiwen Chen; University of Tennessee Health Science Center and Memphis VA Medical Center/Methodist University Hospital ? Csaba P. Kovesdy*, Miklos Z. Molnar*, Ambreen Azhar; University of Texas Southwestern Medical Center and Parkland Health and Hospital System: S. Susan Hedayati*, Mridula V. Nadamuni, Shani Shastri, Duwayne L. Willett; University of Vermont Larner College of Medicine: Samuel A.P. Short; University of Virginia Health System: Amanda D. Renaghan*, Kyle B. Enfield; University of Washington Medical Center: Pavan K. Bhatraju*, A. Bilal Malik; Vanderbilt University Medical Center: Matthew W. Semler; Washington University in St. Louis/Barnes Jewish Hospital: Anitha Vijayan*, Christina Mariyam Joy, Tingting Li, Seth Goldberg, Patricia F. Kao; Wellforce Health System: Lowell General Hospital - Greg L. Schumaker*, Tufts Medical Center - Nitender Goyal*, Anthony J. Faugno, Greg L. Schumaker, Caroline M. Hsu, Asma Tariq, Leah Meyer, Ravi K. Kshirsagar, Aju Jose, Daniel E. Weiner; Westchester Medical Center: Marta Christov*, Savneek Chugh, Jennifer Griffiths, Sanjeev Gupta, Aromma Kapoor, Savneek Chugh; Yale School of Medicine: Perry Wilson,* Tanima Arora, Ugochukwu Ugwuowo. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: HBG receives funding from the University of Miami Hospital and Clinics in support of the UHealth-DART Research Group. AJA receives funding from the National Institutes of Health / National Heart, Lung, and Blood Institute. The funders had no role in the design, execution, or presentation of the study. ABK, SKB, SG, DL, and DEL received no financial support for the research, authorship, and/or publication of this article. Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: HBG receives funding from the University of Miami Hospital and Clinics in support of the UHealth-DART Research Group. AJA receives funding from the National Institutes of Health / National Heart, Lung, and Blood Institute. The funders had no role in the design, execution, or presentation of the study. ABK, SKB, SG, DL, and DEL received no financial support for the research, authorship, and/or publication of this article. Publisher Copyright: © The Author(s) 2021.
PY - 2022/4
Y1 - 2022/4
N2 - Objective: To determine whether surge conditions were associated with increased mortality. Design: Multicenter cohort study. Setting: U.S. ICUs participating in STOP-COVID. Patients: Consecutive adults with COVID-19 admitted to participating ICUs between March 4 and July 1, 2020. Interventions: None Measurements and Main Results: The main outcome was 28-day in-hospital mortality. To assess the association between admission to an ICU during a surge period and mortality, we used two different strategies: (1) an inverse probability weighted difference-in-differences model limited to appropriately matched surge and non-surge patients and (2) a meta-regression of 50 multivariable difference-in-differences models (each based on sets of randomly matched surge- and non-surge hospitals). In the first analysis, we considered a single surge period for the cohort (March 23 – May 6). In the second, each surge hospital had its own surge period (which was compared to the same time periods in matched non-surge hospitals). Our cohort consisted of 4342 ICU patients (average age 60.8 [sd 14.8], 63.5% men) in 53 U.S. hospitals. Of these, 13 hospitals encountered surge conditions. In analysis 1, the increase in mortality seen during surge was not statistically significant (odds ratio [95% CI]: 1.30 [0.47-3.58], p =.6). In analysis 2, surge was associated with an increased odds of death (odds ratio 1.39 [95% CI, 1.34-1.43], p <.001). Conclusions: Admission to an ICU with COVID-19 in a hospital that is experiencing surge conditions may be associated with an increased odds of death. Given the high incidence of COVID-19, such increases would translate into substantial excess mortality.
AB - Objective: To determine whether surge conditions were associated with increased mortality. Design: Multicenter cohort study. Setting: U.S. ICUs participating in STOP-COVID. Patients: Consecutive adults with COVID-19 admitted to participating ICUs between March 4 and July 1, 2020. Interventions: None Measurements and Main Results: The main outcome was 28-day in-hospital mortality. To assess the association between admission to an ICU during a surge period and mortality, we used two different strategies: (1) an inverse probability weighted difference-in-differences model limited to appropriately matched surge and non-surge patients and (2) a meta-regression of 50 multivariable difference-in-differences models (each based on sets of randomly matched surge- and non-surge hospitals). In the first analysis, we considered a single surge period for the cohort (March 23 – May 6). In the second, each surge hospital had its own surge period (which was compared to the same time periods in matched non-surge hospitals). Our cohort consisted of 4342 ICU patients (average age 60.8 [sd 14.8], 63.5% men) in 53 U.S. hospitals. Of these, 13 hospitals encountered surge conditions. In analysis 1, the increase in mortality seen during surge was not statistically significant (odds ratio [95% CI]: 1.30 [0.47-3.58], p =.6). In analysis 2, surge was associated with an increased odds of death (odds ratio 1.39 [95% CI, 1.34-1.43], p <.001). Conclusions: Admission to an ICU with COVID-19 in a hospital that is experiencing surge conditions may be associated with an increased odds of death. Given the high incidence of COVID-19, such increases would translate into substantial excess mortality.
KW - COVID-19
KW - intensive care unit
KW - mortality
KW - occupancy
KW - surge
UR - http://www.scopus.com/inward/record.url?scp=85122130775&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122130775&partnerID=8YFLogxK
U2 - 10.1177/08850666211067509
DO - 10.1177/08850666211067509
M3 - Article
C2 - 34939474
AN - SCOPUS:85122130775
VL - 37
SP - 500
EP - 509
JO - Journal of Intensive Care Medicine
JF - Journal of Intensive Care Medicine
SN - 0885-0666
IS - 4
ER -